# A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles

> **NCT00631124** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 103 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** BAY86-4891 (Estradiol / Drospirenone)
- **DRUG:** BAY86-4891 (Estradiol / Drospirenone)

## Key facts

- **NCT ID:** NCT00631124
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-10
- **Final completion:** 2008-12
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2014-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00631124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00631124, "A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00631124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*